Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
MnZgkPFKGqBBTD9J
